K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
基本信息
- 批准号:8096817
- 负责人:
- 金额:$ 30.88万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2010
- 资助国家:美国
- 起止时间:2010-07-01 至 2015-04-30
- 项目状态:已结题
- 来源:
- 关键词:Acquired Immunodeficiency SyndromeAffectApplications GrantsB-Cell LymphomasBindingBinding ProteinsBiochemical GeneticsBiological ProcessBody cavitiesCancer EtiologyCell physiologyCellsChromatinChromatin StructureChromosomesComplexCoupledDataDefectDevelopmentDiseaseEnvironmentEpigenetic ProcessEpisomeEukaryotaEukaryotic CellExhibitsGene ExpressionGene Expression RegulationGenetic TranscriptionHIVHerpesviridaeHeterochromatinHistonesHumanIn VitroKaposi SarcomaKnowledgeLife Cycle StagesLigaseLinkLymphomaLyticMalignant - descriptorMalignant NeoplasmsMediatingMethodsModelingModificationMolecularMulticentric Angiofollicular Lymphoid HyperplasiaMutateOncogenicPathway interactionsPatientsPhasePhosphorylationPlayPost-Translational Protein ProcessingProcessProteinsRecruitment ActivityRegulationResearchRoleSignal PathwaySignal TransductionSignaling MoleculeStreamStructureTestingTrans-ActivatorsTranslationsUbiquitinViralViral GenesViral GenomeViral ProteinsVirusVirus Latencyantigen bindingbasebody cavitycell transformationchromatin immunoprecipitationchromatin modificationchromatin proteinchromatin remodelingeffusioninfectious disease treatmentinnovationinsightlatency-associated nuclear antigenlatent gene expressionmutantnovelparacrineprotein Kpublic health relevancereactivation from latencytranscription factortumorigenicubiquitin ligaseubiquitin-protein ligase
项目摘要
DESCRIPTION (provided by applicant): Epigenetic regulation of gene expression plays a critical role in many fundamental biological processes in eukaryotes. We have focused on defining epigenetic mechanisms, involving post-translation modification of chromatin proteins, in the life cycle of Kaposi's sarcoma herpesvirus (KSHV), which is an etiological agent of Kaposi's sarcoma (KS), an AIDS-associated malignancy. This virus exhibits a latent phase in infected cells in which only a few viral genes are expressed. Cell signaling pathways can reactivate latent cells to produce virus through a temporal cascade that regulates expression of nearly 100 viral genes. Thus, KSHV is a very attractive model to study epigenetic mechanisms that affect chromatin structure and dynamics, which are key processes regulating transcription in eukaryotic cells. The small ubiquitin-like modifier (SUMO) is a protein that regulates a wide variety of cellular processes, including heterochromatin formation, by covalent attachment (i.e. sumoylation) to a diverse array of target proteins. Sumoylation, like phosphorylation, serves as a post-translational signal molecule to transmit signals to down-stream targets containing a SUMO-interacting motif (SIM); these targets include proteins that impact chromatin structure that generally silence transcription. Our recent studies show that the main viral transcriptional transactivator, K-Rta, is a SUMO-targeting ubiquitin (Ub) ligase, which degrades SUMO- modified proteins. We hypothesize that this SUMO-targeting Ub ligase function is important for K-Rta to initiate the lytic (productive) phase of KSHV replication by disrupting the repressive environment surrounding of the viral episome in latently infected cells. This repressive environment is established by the viral latency- associated nuclear antigen (LANA), which is a SUMO-binding protein that tethers viral episomes to heterochromatic regions of host cell chromosomes and thereby maintains the latent state of the virus. This proposal will test the hypothesis that the regulation of SUMO modification plays a key role in the KSHV life cycle in both establishment of latency and reactivation of this virus by modulating the structure of viral chromatin. In the first Aim, we will investigate the role of K-Rta as a SUMO-dependent ubiquitin ligase in KSHV replication. In the second Aim, the potential mechanisms whereby K-Rta acts in a SUMO-dependent manner and affects the epigenetic signature of viral chromatin will be analyzed. Taken together, these studies will define a new role of K-Rta, as well as LANA, in KSHV replication, and will provide insights into the post- translational modifications and chromatin remodeling that govern latency and reactivation.
PUBLIC HEALTH RELEVANCE: The research in this R01 grant application on KSHV will produce a new understanding of regulation of gene expression and epigenetic control. Our research will provide fundamental knowledge regarding the mechanisms of viral reactivation and could produce innovative approaches for the treatment of infectious disease, especially cancer caused by this tumorigenic virus.
描述(由申请人提供):基因表达的表观遗传调控在真核生物的许多基本生物过程中起着关键作用。我们一直专注于定义表观遗传机制,涉及染色质蛋白的翻译后修饰,在卡波西肉瘤疱疹病毒(KSHV)的生命周期中,这是卡波西肉瘤(KS),艾滋病相关的恶性肿瘤的病原体。该病毒在感染细胞中表现出潜伏期,其中仅表达少数病毒基因。细胞信号通路可以通过一个时间级联反应重新激活潜伏细胞产生病毒,该级联反应调节近100个病毒基因的表达。因此,KSHV是一个非常有吸引力的模型来研究影响染色质结构和动力学的表观遗传机制,这是真核细胞中调控转录的关键过程。 小泛素样修饰物(SUMO)是一种通过共价连接(即SUMO化)到多种靶蛋白上来调节多种细胞过程(包括异染色质形成)的蛋白质。SUMO化,像磷酸化一样,作为翻译后信号分子将信号传递到含有SUMO相互作用基序(SIM)的下游靶标;这些靶标包括影响染色质结构的蛋白质,这些蛋白质通常使转录沉默。我们最近的研究表明,主要的病毒转录反式激活因子,K-Rta,是一个SUMO靶向泛素(Ub)连接酶,降解SUMO修饰的蛋白质。我们假设这种SUMO靶向的Ub连接酶功能对于K-Rta通过破坏潜伏感染细胞中病毒附加体周围的抑制环境来启动KSHV复制的裂解(生产)阶段是重要的。这种抑制性环境由病毒潜伏相关核抗原(拉娜)建立,LANA是一种SUMO结合蛋白,其将病毒附加体束缚到宿主细胞染色体的异染色质区域,从而维持病毒的潜伏状态。该提案将测试这一假设,即SUMO修饰的调节在KSHV生命周期中起着关键作用,通过调节病毒染色质的结构来建立潜伏期和重新激活该病毒。在第一个目标中,我们将研究K-Rta作为SUMO依赖性泛素连接酶在KSHV复制中的作用。在第二个目标中,将分析K-Rta以SUMO依赖性方式起作用并影响病毒染色质的表观遗传特征的潜在机制。总之,这些研究将确定K-Rta以及拉娜在KSHV复制中的新作用,并将提供对控制潜伏期和再活化的翻译后修饰和染色质重塑的见解。
公共卫生关系:这项关于KSHV的R 01资助申请的研究将对基因表达调控和表观遗传控制产生新的理解。我们的研究将提供有关病毒再激活机制的基础知识,并可能产生治疗感染性疾病的创新方法,特别是由这种致瘤病毒引起的癌症。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Yoshihiro Izumiya其他文献
Yoshihiro Izumiya的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Yoshihiro Izumiya', 18)}}的其他基金
Studies on Epigenetically Active Latent Chromatin Maintenance
表观遗传活性潜在染色质维持的研究
- 批准号:
10570202 - 财政年份:2022
- 资助金额:
$ 30.88万 - 项目类别:
Development of Precision Analyses to Reveal "Hit&Run" Effects
开发精密分析以揭示“命中”
- 批准号:
10095754 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Development of Precision Analyses to Reveal Hit&RunÃÂ Effects
开发精确分析以揭示命中
- 批准号:
10316988 - 财政年份:2020
- 资助金额:
$ 30.88万 - 项目类别:
Spatiotemporal Gene Regulation and KSHV Replication
时空基因调控和 KSHV 复制
- 批准号:
10436841 - 财政年份:2018
- 资助金额:
$ 30.88万 - 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
- 批准号:
9902205 - 财政年份:2018
- 资助金额:
$ 30.88万 - 项目类别:
Spatiotemporal Gene Regulation and KSHV Replication
时空基因调控和 KSHV 复制
- 批准号:
10203870 - 财政年份:2018
- 资助金额:
$ 30.88万 - 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
- 批准号:
10437848 - 财政年份:2018
- 资助金额:
$ 30.88万 - 项目类别:
Nano-Therapeutic Approaches for Oncogenic Herpesvirus-Mediated Malignancies
疱疹病毒介导的致癌性恶性肿瘤的纳米治疗方法
- 批准号:
10203875 - 财政年份:2018
- 资助金额:
$ 30.88万 - 项目类别:
K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
- 批准号:
8462230 - 财政年份:2010
- 资助金额:
$ 30.88万 - 项目类别:
K-Rta as a Novel SUMO and Epigenetic Regulator
K-Rta 作为新型相扑和表观遗传调节剂
- 批准号:
8247666 - 财政年份:2010
- 资助金额:
$ 30.88万 - 项目类别:
相似海外基金
RII Track-4:NSF: From the Ground Up to the Air Above Coastal Dunes: How Groundwater and Evaporation Affect the Mechanism of Wind Erosion
RII Track-4:NSF:从地面到沿海沙丘上方的空气:地下水和蒸发如何影响风蚀机制
- 批准号:
2327346 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Standard Grant
BRC-BIO: Establishing Astrangia poculata as a study system to understand how multi-partner symbiotic interactions affect pathogen response in cnidarians
BRC-BIO:建立 Astrangia poculata 作为研究系统,以了解多伙伴共生相互作用如何影响刺胞动物的病原体反应
- 批准号:
2312555 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Standard Grant
How Does Particle Material Properties Insoluble and Partially Soluble Affect Sensory Perception Of Fat based Products
不溶性和部分可溶的颗粒材料特性如何影响脂肪基产品的感官知觉
- 批准号:
BB/Z514391/1 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Training Grant
Graduating in Austerity: Do Welfare Cuts Affect the Career Path of University Students?
紧缩毕业:福利削减会影响大学生的职业道路吗?
- 批准号:
ES/Z502595/1 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Fellowship
Insecure lives and the policy disconnect: How multiple insecurities affect Levelling Up and what joined-up policy can do to help
不安全的生活和政策脱节:多种不安全因素如何影响升级以及联合政策可以提供哪些帮助
- 批准号:
ES/Z000149/1 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Research Grant
感性個人差指標 Affect-X の構築とビスポークAIサービスの基盤確立
建立个人敏感度指数 Affect-X 并为定制人工智能服务奠定基础
- 批准号:
23K24936 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Grant-in-Aid for Scientific Research (B)
How does metal binding affect the function of proteins targeted by a devastating pathogen of cereal crops?
金属结合如何影响谷类作物毁灭性病原体靶向的蛋白质的功能?
- 批准号:
2901648 - 财政年份:2024
- 资助金额:
$ 30.88万 - 项目类别:
Studentship
ERI: Developing a Trust-supporting Design Framework with Affect for Human-AI Collaboration
ERI:开发一个支持信任的设计框架,影响人类与人工智能的协作
- 批准号:
2301846 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Standard Grant
Investigating how double-negative T cells affect anti-leukemic and GvHD-inducing activities of conventional T cells
研究双阴性 T 细胞如何影响传统 T 细胞的抗白血病和 GvHD 诱导活性
- 批准号:
488039 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Operating Grants
How motor impairments due to neurodegenerative diseases affect masticatory movements
神经退行性疾病引起的运动障碍如何影响咀嚼运动
- 批准号:
23K16076 - 财政年份:2023
- 资助金额:
$ 30.88万 - 项目类别:
Grant-in-Aid for Early-Career Scientists














{{item.name}}会员




